AzTrials
AzTrials

Inguinal Hernia, Without Mention of Obstruction or GangreneNCT07902167

Evaluating the Efficacy and Safety of a New Laparoscopic Non-mesh Hernia Needle Set Designed for Indirect Inguinal Hernia

A study testing non-mesh inguinal hernia needle and conventional needle set in people with Inguinal Hernia, Without Mention of Obstruction or Gangrene, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This is a prospective, single-blinded and randomized clinical trial, and will be conducted at Chang Gung Memorial Hospital Chiayi branch in Taiwan. 1. Why is this study being done? Inguinal hernia is a common condition in adults. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
non-mesh inguinal hernia needle and conventional needle set
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
96 participants
Where
1 siteTaiwan
Study dates
4 Mar 2026to 30 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participant is willing and able to give written informed consent for participation in the trial.
  • Adults (more than 18 years old) with inguinal hernia.
  • Do not want to undergo traditional open hernia surgery, but willing to undergo single-port laparoscopy to determine the hernia type.
  • For the indirect hernia, the participant is willing to undergo percutaneous internal ring suture by using either the ready-made or neoteric needle set decided by us randomly.
  • If employees or students of the study institution are considered for participation, they may be enrolled only if all of the following conditions are met:
  • They satisfy all inclusion criteria specified in this study protocol.
  • The investigator and research personnel involved in recruitment are not the participant's direct supervisor, instructor, or evaluator, and have no responsibility for assessing the participant's academic, employment, or professional performance.
  • Recruitment is conducted in a manner that minimizes the possibility of coercion or undue influence. Participants shall not be recruited through individual solicitation by their supervisors, instructors, or evaluators.

Who cannot join

  • Pregnant women.
  • Obesity: Body mass index (BMI) ≧35.
  • Recurrent hernia after any hernia surgery.
  • Insufficient level of language to understand all study requirements in opinion of the investigators.
  • Hydroceles with multiple septations and complex anatomy.
  • Incarcerated or strangulated hernias.
Show all 13Show fewer
  • Known connective tissue disorders (e.g., Loeys-Dietz, Marfan syndrome).
  • High bleeding tendency during surgery.
  • Technical conversion triggers: large hernias, edema, poor visualization.
  • Severe cardiopulmonary compromise.
  • Extensive intra-abdominal adhesions (e.g., from prior surgeries or infections).
  • Allergy to the materials of the medical devices used in this study (such as stainless steel and suture materials).
  • Patients asked for mesh repair for their inguinal hernia initially.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Chang Gung Memorial Hospital

    Chiayi City

Other trials in Taiwan

About this study

Official title: Evaluating the Effectiveness and Safety of Laparoscopic Non-mesh Hernia Needle Set

This is a prospective, single-blinded and randomized clinical trial, and will be conducted at Chang Gung Memorial Hospital Chiayi branch in Taiwan.

  1. Why is this study being done? Inguinal hernia is a common condition in adults. It can be classified into different types, and more than half of adult inguinal hernias are belonged to the "indirect" type. Traditionally, inguinal hernias are repaired with artificial mesh in adults. Since 2018, we use the laparoscopy-assisted percutaneous internal ring suture (PIRS), which has been proofed to be safe and effectiveness in repairing the pediatric indirect inguinal hernia, to treat the adult indirect inguinal hernias. More than 150 adult patients were treated by using this method with good results and low recurrence rate. However, conventional needles for the pediatric group are too short and weak to operate on the adult group. Now there is a new device, laparoscopic non-mesh hernia needle set, designed specifically for adults. We would like to evaluate whether this new device can: (1) Shorten the operation time; (2) Reduce postoperative pain; (3) Maintain a low recurrence rate
  2. What will happen to the participants
Read more

The participants, whose hernia confirmed to be the indirect type under laparoscopic inspection, would be randomly assigned to one of two groups:

(1) The control group: using conventional needle set for PIRS; (2) The experimental group: using laparoscopic non-mesh hernia needle set for PIRS.

Both groups would undergo the same surgical method except the needle devices. For the participants with inguinal hernias other than the indirect type, an adequate mesh repair be performed according to the Guideline of Hernia Surg (Hernia. 2018; 22(1): 17-18)

After surgery, three follow-up visits within six months would be arranged to all participants. Each visit will take about one hour. During these visits, we will:

(1) Record about recovery and pain conditions; (2) Check surgical wound; (3) Evaluate whether the hernia has recurred.

  1. What are the possible complications? The risks of surgery are similar whether the participants join the study or not. Possible complications include: (1) Postoperative pain; (2) Hernia recurrence; (3) Wound infection; (4) Bruising or bleeding under the skin at the needle site

This study will help us to determine whether the new needle set could decrease the complication rate.

  1. Participation in this study is completely voluntary. For the patients unwilling to participate this study, they will receive the standard procedures at present, including: (1) Open hernia repair with mesh, Lichtenstein method. (2) Laparoscopic hernia repair with mesh, TEP or TAPP. (3) Laparoscopic repair using the conventional hernia needle
Read the detailed description

Hernia, a common human disease, is defined as any organ or tissue leaving its normal location via congenital or acquired weak point, defect or fissure. Hernia frequently develops in inguinal (inguinal hernia), femoral (femoral hernia), umbilical (umbilical hernia), incision (incisional hernia) or diaphragmatic areas (diaphragmatic hernia).

Inguinal hernia accounts for more than 90% of all hernia. It is estimated 27% male and 3% female would be bothered by the inguinal hernia throughout the life. There were about 30 thousands of surgeries for hernia in Taiwan, and about 20 millions of surgeries for hernia worldwide annually. Inguinal hernia is classified into direct and indirect type. When testes passed through the inguinal canals into the scrotum before or after birth, the internal ring of inguinal canal would close gradually. Indirect type of inguinal hernia is abdominal organs or tissues enter the inguinal canal due to non-obliteration of internal ring. When inguinal hernia develops, one protruding mass would be seen on the groin area, and the patient feel pain and swelling. If the hernia could not be reduced spontaneously, the organ/tissue in the hernia sac would undergo blood supply disturbance, and organ/tissue necrosis, bowel perforation, even death follows. Surgery is usually suggested if one patient is diagnosed with inguinal hernia.

Open herniorrhaphy, which ligating the internal ring in the pre-peritoneal layer and then removing the hernia sac, is used to manage the indirect type of inguinal hernia traditionally. Incidence of inguinal hernia in children is about 5-6%, and almost is indirect type. Most patients are newborn to 6 years old. In 2006, Dr. Patkowski published percutaneous internal ring suture (PIRS) under laparoscopy. In PIRS the inner ring opening is closed by suture line in the pre-peritoneal layer under single-port laparoscopy. The hernia sac is remained without removal. It differs from the open herniorrhaphy is that the knots will tie the peritoneal layer and musculo-fascial layer at the same time, and patients were more painful after surgery. After 20-year observations, there was little difference found in the operation time and hernia recurrence rate between the open herniorrhaphy and PIRS. Surgical scars were smaller after PIRS, and it made PIRS being the routine surgery for indirect inguinal hernia in several children's hospitals in the America and Europe. In our hospital, there were more than 300 children with indirect inguinal hernia underwent single port laparoscopic PIRS since 2016. The operation time was less than 20 minutes in average. These children did not need admission, their recovery time was shorter, and the hernia recurrence rate was zero.

In adults, their inguinal hernia could be indirect, direct even mixed types. Inguinal hernia typing in adults often is not confirmed actually before surgery, yet the problem could be resolved during laparoscopy. Traditionally the main surgical method was to repair the inguinal hernia with mesh in the Hesselbach's triangle regardless of hernia type. The method could not satisfy every patient's requirement, and the overall hernia recurrence rate is 30-50%. In fact, 67-82% of adult cases with inguinal hernia belonged to the indirect type according to the published researches. Therefore, we thought single port laparoscopic PIRS could be utilized in adults also. In past 6 years, more than 100 adults underwent single port laparoscopic PIRS at our hospital for their indirect inguinal hernia. Hernia recurrence and chronic pain rate were 5%.

There is one new inguinal ring repair needle set developed recently, and which is suitable for single-port laparoscopic hernia surgery. The needle set is composed of puncture needle and suture guide needle. The puncture needle is composed of outer and inner sheath, and it can easily puncture and peel off the tissue. When the puncture needle arrives the inner ring of inguinal canal, removing the inner sheath, and outer sheath is left in the musculo-fascial layer. The suture guide needle is inserted into the outer sheath to tie and close the inner ring. The knot will naturally penetrate the muscular layer and stay on the peritoneal layer. In general, this hernia needle set can solve the inconvenience during the surgery and post-operative pain of patients.

This is a single-blind and randomized study to evaluate the safety and efficacy of the new inguinal needle set in managing the adults' indirect inguinal hernia.

  • Trial period: Two years.
  • Grouping: Divided into control and study group (sample size: 48 cases more than 18 years old in each group)
  • Random sampling: participants will be randomized equally to receive ready-made or new needle set for inguinal hernia.
  • Control group: Patients with indirect inguinal hernia and undergoing laparoscopic percutaneous internal ring suture via ready-made needle set.
  • Trial period: 2025-05-01 to 2027-04-30.
  • Follow-up period after surgery: six months.
  • Test execution location: Chang Gung Memorial Hospital at Chiayi, Taiwan.
  • Belonged to single center trial.
  • Confidentiality of subject information: If the medical records would be used for reports and analysis, the subjects will be identified with codes and personal informations will be removed.
  • Medical records would be used: (1) basic data: age, body height, body weight, BMI, hernia side, obliteration of the contralateral processus vaginalis, operation time, hospitalization days; (2) out-patient department follow up: post-operational pain severity and duration evaluated by Mankoski Pain Scale, analgesics kinds and frequencies, days for wound recovery, days for recovery of daily activities evaluated by Mankoski Pain Scale , hernia recurrence at the operational side.
  • The primary endpoint: post-operational pain score
Being tested
non-mesh inguinal hernia needle, conventional needle set
Medical subject headings
Hernia, Inguinal, Gangrene

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • non-mesh inguinal hernia needleDevice

    Non-mesh inguinal hernia needle is used for indirect inguinal hernia repair by laparoscopy. It is composed of puncture needle and suture needle.

  • conventional needle setDevice

    Conventional needle set is used traditionally for percutaneous internal ring suture in Chang Gung Memorial Hospital at Chiayi, Taiwan.

Study groups in NCT07902167
Study groupRoleWhat they receive
ExperimentalExperimentalnon-mesh inguinal needle set
Receives: Device: non-mesh inguinal hernia needle
ControlActive comparatorconventional needle set
Receives: Device: conventional needle set
AdditionalNo interventionenrolled patients without indirect inguinal hernia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. post operational pain

    Evaluated by Mankoski Pain Scale (score 0-10, zero is equivalent to no pain and 10 indicates the worst possible pain) on the operation day and one week after surgery, and recording frequency and kinds of analgesics used after surgery by charts

    Measured: From enrollment to the end of treatment at 24 weeks

Secondary outcomes (4)
  1. Operation time

    The operation time, measured in minutes, is defined as the time elapsed from insertion of the trocar through the umbilicus to its removal from the umbilicus at the end of the operation.

    Measured: During the surgery

  2. Time to resumption of daily activities

    The number of days from surgery until the patient resumes usual daily activities, including work, exercise, and household activities.

    Measured: From enrollment to the end of treatment at 24 weeks

  3. Ipsilateral inguinal hernia recurrence rate within six months after surgery

    The proportion of patients who develop recurrent inguinal hernia on the operated side within six months after surgery. The recurrence rate will be calculated as the number of patients with recurrence divided by the total number of patients evaluated for recurrence, multiplied by 100%.

    Measured: From enrollment to the end of treatment at 24 weeks

  4. Wound infection rate

    The proportion of patients who develop a surgical wound infection following surgery during the prespecified follow-up period. The wound infection rate will be calculated as the number of patients with a wound infection divided by the total number of patients evaluated for wound infection, multiplied by 100%.

    Measured: From enrollment to the end of treatment at 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2026
  2. Study start4 Mar 2026
  3. Primary completion30 Apr 2027 (estimated)
  4. Study completion30 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Enrolled patients would undergo laparoscopy to confirm their inguinal hernia type. For the patients with indirect-type inguinal hernia, their internal ring of inguinal canal would be sutured by non-mesh inguinal needle set or conventional needle set randomly.
Masking
Single blind
Who is masked
Participant
Enrolment
96 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07902167
Sponsor's protocol ID
202500373A0C6001
Other IDs
NSTC 114-2823-8-182A-001
Status last verified
Jun 2026
First submitted
2 Mar 2026
Last updated
28 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wang SH, Lee CY, Hsieh WC, Yen JB, Tseng IM, Wong CH, Ho DR. Tailored treatment of female indirect inguinal hernias by using single-port laparoscopic percutaneous internal ring suture: a comparison between children and adults. Hernia. 2024 Aug;28(4):1365-1372. doi: 10.1007/s10029-024-03055-3. Epub 2024 May 22.

    PubMed 38775981
  • Wang SH, Yen JB, Hsu SL. The application of single-port laparoscopic percutaneous internal ring suture for the management of indirect inguinal hernia in female adults. Sci Rep. 2020 Oct 1;10(1):16244. doi: 10.1038/s41598-020-73171-4.

    PubMed 33004858

Questions about this trial

What is this clinical trial studying?

A study testing non-mesh inguinal hernia needle and conventional needle set in people with Inguinal Hernia, Without Mention of Obstruction or Gangrene, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

post operational pain (time frame: From enrollment to the end of treatment at 24 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07902167, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in